Minodronic Acid Hydrate | m-entrepreneurship.com

Product Name :
Minodronic Acid Hydrate

Search keywords :
FDPS

drugId :
null

Target Vo:
Farnesyl diphosphate synthase

Target Vo Short Name :
FDPS

Moa_Name:
Farnesyl diphosphate synthase inhibitors

First Approval Country :
Japan

First Approval Date Filter:
2009

Origin Company_Name :
Ono Pharmaceutical Co Ltd

Active Company_Name :
Astellas Pharma Inc

Active Indication_Name:
Osteoporosis

In Active Indication_Name:
Bone Diseases

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
LIAS Antibody
Phospho-Hsp27 (Ser78) Antibody
Phospho-BRAF (Thr401) Antibody: Phospho-BRAF (Thr401) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 84 kDa, targeting to Phospho-BRAF (Thr401). It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts